Bnp Paribas Asset Management Holding S.A. Ultragenyx Pharmaceutical Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.3 Billion
- Q4 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 958,077 shares of RARE stock, worth $40.7 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
958,077
Previous 724,182
32.3%
Holding current value
$40.7 Million
Previous $40.2 Million
0.2%
% of portfolio
0.1%
Previous 0.1%
Shares
6 transactions
Others Institutions Holding RARE
# of Institutions
344Shares Held
86.6MCall Options Held
637KPut Options Held
845K-
Vanguard Group Inc Valley Forge, PA10MShares$426 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$238 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$183 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$116 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$107 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.98B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...